Sign in

CIK 0001997038

Iambic Therapeutics, Inc.

Sign in to watch
Ticker
IAM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
other
EIN
843364168
Phone
(626) 592-2520
Business address
5627 OBERLIN DRIVE, SUITE 120, SAN DIEGO, CA, 92121
Open-market buys, last 90 days
$11,500,000
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$11,500,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Rachlin Evan Lockwood +$11.5M Director 1 filing
Date Insider Transaction Shares Price Value Owned after
2026-10-16 Catalio Capital Management, LP 10% owner Conversion · Series B Convertible Preferred Stock −731,187 0
2026-10-16 Catalio Capital Management, LP 10% owner Conversion · Series B-3 Convertible Preferred Stock −122,684 0
2026-10-16 Catalio Capital Management, LP 10% owner Conversion · Series B-4 Convertible Preferred Stock −1,458,290 0
2026-10-16 Catalio Capital Management, LP 10% owner Conversion · Convertible Promissory Notes −742,546 0
2026-10-16 Secora Michael CFO & Chief Corp Dev Ofcr Conversion +61,342 279,902
2026-10-16 Secora Michael CFO & Chief Corp Dev Ofcr Conversion · Series B-3 Convertible Preferred Stock −61,342 0
2026-10-16 RASTETTER WILLIAM H Director Conversion +192,579 192,579
2026-10-16 RASTETTER WILLIAM H Director Conversion +8,341 200,920
2026-10-16 RASTETTER WILLIAM H Director Conversion · Series B Convertible Preferred Stock −76,801 0
2026-10-16 RASTETTER WILLIAM H Director Conversion · Series B-2 Convertible Preferred Stock −64,001 0
2026-10-16 RASTETTER WILLIAM H Director Conversion · Series B-3 Convertible Preferred Stock −36,805 0
2026-10-16 RASTETTER WILLIAM H Director Conversion · Series B-4 Convertible Preferred Stock −14,972 0
2026-10-16 RASTETTER WILLIAM H Director Conversion · Convertible Promissory Notes −8,341 0
2026-10-14 Manby Frederick R Chief Technology Officer Grant or award +132,200 1,862,665
2026-10-14 Manby Frederick R Chief Technology Officer Grant or award · Employee Stock Option (right to buy) +793,200 793,200
2026-10-14 Olson Peter A Chief Scientific Officer Grant or award +19,500 30,909
2026-10-14 Olson Peter A Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +116,900 116,900
2026-10-14 Vogelstein R Jacob Director Grant or award · Stock Option (right to buy) 10b5-1 +20,300 20,300
2026-10-14 Rachlin Evan Lockwood Director Grant or award · Stock Option (right to buy) +20,300 20,300
2026-10-14 Miller Thomas F. Chief Executive Officer Grant or award +132,200 1,410,756

Page 2 of 3 · 49 trades